Intake of plant foods and associated nutrients in prostate cancer risk

Nutrition and Cancer

Volumn 61, Issue 2, 2009, Pages 216-224

  Lewis, John E ^a   Soler Vilá, Hosanna ^b   Clark, Peter E ^c   Kresty, Laura A ^a   Allen, Glenn O ^a   Hu, Jennifer J ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ASCORBIC ACID; BETA CAROTENE; CRYPTOXANTHIN; DAIDZEIN; FOLIC ACID; GENISTEIN; PROTEIN; RETINOL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CANCER SURVIVOR; CAUCASIAN; CONTROLLED STUDY; DIETARY FIBER; ETHNICITY; FOOD INTAKE; FRUIT; FRUIT JUICE; GRAIN; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT; PREVALENCE; PROSTATE CANCER; RACE DIFFERENCE; VEGETABLE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CEREALS; DIET; DIET RECORDS; DIETARY PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLAVONOIDS; FRUIT; HUMANS; MALE; MIDDLE AGED; PLANTS, EDIBLE; PROSTATIC NEOPLASMS; QUESTIONNAIRES; VEGETABLES; VITAMINS;

EID: 61649097296     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802419756     Document Type: Article

References (47)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al.: Cancer statistics, 2008. CA Cancer J Clin 58, 71-96, 2008.
2. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society, 2007.
3. Gallus S, Foschi R, Talamini R, Altieri A, Negri E, et al.: Risk factors for prostate cancer in men aged less than 60 years: a case-control study from Italy. Urology 70, 1121-1126, 2007.
4. Hu JJ, Hall MC, Grossman L, Hedayati M, McCullough DL, et al.: Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res 64, 1197-1201, 2004.
5. Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, et al.: The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 64, 6344-6348, 2004.
6. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, et al.: Multiple Loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100, 962-966, 2008.
7. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, et al.: Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40, 281-283, 2008.
8. Bruner DW, Moore D, Parlanti A, Dorgan J, and Engstrom P: Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107, 797-803, 2003.
9. Demark-Wahnefried W, Aziz NM, Rowland JH, and Pinto BM: Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23, 5814-5830, 2005.
10. Chan JM, Gann PH, and Giovannucci EL: Role of diet in prostate cancer development and progression. J Clin Oncol 23, 8152-8160, 2005.
11. Wigle DT, Turner MC, Gomes J, and Parent ME: Role of hormonal and other factors in human prostate cancer. J Toxicol Environ Health B Crit Rev 11, 242-259, 2008.
12. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768-780, 2003.
13. Thorpe JF, Jain S, Marczylo TH, Gescher AJ, Steward WP, et al.: A review of phase III clinical trials of prostate cancer chemoprevention. Ann R Coll Surg Engl 89, 207-211, 2007.
14. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr., et al.: Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 97, 94-102, 2005.
15. Zhang J, Dhakal I, Stone A, Ning B, Greene G, et al.: Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas. Nutr Cancer 59, 46-53, 2007.
16. Vainio H and Weiderpass E: Fruit and vegetables in cancer prevention. Nutr Cancer 54, 111-142, 2006.
17. McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, et al.: Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53, 33-41, 2005.
18. Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, et al.: Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer 50, 206-213, 2004.
19. Ambrosini GL, de Klerk NH, Fritschi L, Mackerras D, and Musk B: Fruit, vegetable, vitamin A intakes, and prostate cancer risk. Prostate Cancer Prostatic Dis 11, 61-66, 2008.
20. Etminan M, Takkouche B, and Caamano-Isorna F: The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 13, 340-345, 2004.
21. Dalais FS, Meliala A, Wattanapenpaiboon N, Frydenberg M, Suter DA, et al.: Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology 64, 510-515, 2004.
22. Yan L and Spitznagel EL: Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 117, 667-669, 2005.
23. Shukla S and Gupta S: Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 53, 18-32, 2005.
24. Neuhouser ML: Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50, 1-7, 2004.
25. Kavanaugh CJ, Trumbo PR, and Ellwood KC: The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst 99, 1074-1085, 2007.
26. Peters U, Littman AJ, Kristal AR, Patterson RE, Potter JD, et al.: Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control 19, 75-87, 2008.
27. Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, et al.: Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16, 962-968, 2007.
28. Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, et al.: Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 60, 361-364, 1995.
29. Ferdowsian HR and Barnard ND: The role of diet in breast and prostate cancer survival. Ethn Dis 17, S2-S22, 2007.
30. Harman SM, Metter EJ, Blackman MR, Landis PK, and Carter HB: Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 85, 4258-4265, 2000.
31. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, et al.: Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92, 1910-1917, 2000.
32. Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, et al.: Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 10, 421-427, 2001.
33. McGreevy KM, Hoel BD, Lipsitz SR, and Hoel DG: Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males. Public Health Nutr 10, 97-105, 2007.
34. Lockett KL, Hall MC, Clark PE, Chuang SC, Robinson B, et al.: DNA damage levels in prostate cancer cases and controls. Carcinogenesis 27, 1187-1193, 2006.
35. Block G: A review of validations of dietary assessment methods. Am J Epidemiol 115, 492-505, 1982.
36. Block G, Thompson FE, Hartman AM, Larkin FA, Guire KE: Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 92, 686-693, 1992.
37. Block G, Woods M, Potosky A, Clifford C: Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43, 1327-1335, 1990.
38. Shaya FT, Gbarayor CM, Huiwen KY, Gyeman-Duah M, and Saunders E: A perspective on African American participation in clinical trials. Contemp Clin Trials 28, 213-217, 2007.
39. Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, et al.: Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 98, 1574-1581, 2008. 3
40. Bidoli E, Talamini R, Bosetti C, Negri E, Maruzzi D, et al.: Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol 16, 152-157, 2005.
41. Bosetti C, Micelotta S, Dal ML, Talamini R, Montella M, et al.: Food groups and risk of prostate cancer in Italy. Int J Cancer 110, 424-428, 2004.
42. Grainger EM, Kim HS, Monk JP, Lemeshow SA, Gong M, et al.: Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center. Urol Oncol 26, 125-132, 2008.
43. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.
44. Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, et al.: A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15, 92-98, 2006.
45. Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, et al.: Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 47, 111-117, 2003.
46. Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, et al.: Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 158, 1-13, 2003.
47. Berkow SE, Barnard ND, Saxe GA, and Ankerberg-Nobis T: Diet and survival after prostate cancer diagnosis. Nutr Rev 65, 391-403, 2007.